⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
Aronora Appoints Industry Leaders to Drive Next Phase of Growth
globenewswire.com
GILD
EXAS
RLMD
AbTherx and Red Queen Bio Partner on Therapeutic Antibody Discovery
accessnewswire.com
GILD
Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight
prnewswire.com
TAK
JNJ
CANF
AMGN
ABBV
NVS
BMY
AZN
BHC
LLY
UCB
LEO
REGN
XBI
IBB
JAZZ
MRK
SNY
GILD
INCY
PFE
LULU
PRTH
DRH
BIIB
TEVA
ARCT
HRMY
CRSP
NTLA
EDIT
SNOW
DDOG
CRM
GOOG
MSFT
AAPL
AMZN
TSLA
NVDA
META
NFLX
DIS
CMCSA
VZ
T
KO
PEP
MCD
SBUX
HD
EXAS
ILMN
BNTX
MRNA
XOM
CVX
BA
CAT
GE
IBM
INTC
CSCO
ADBE
QCOM
AMAT
MU
ORCL
ACN
COST
WMT
TGT
LOW
HON
GD
LMT
RTX
BAX
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
businesswire.com
RIGL
GILD
ARCX
TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook 2026-2030 with Focus on US, China, South Korea, Australia, and Europe - ResearchAndMarkets.com
businesswire.com
GILD
MRK
CGEN
VIR
Biotechnology Instruments Market Projected to Reach US$ 141.70 Billion by 2035 | Astute Analytica
globenewswire.com
ILMN
TMO
BRKR
LLY
ONON
PACB
RGEN
QGEN
AMGN
BMY
GILD
NVO
ANTX
DTIL
AGNC
DHR
RAAP: Alternative Funding Programs Put Rare Patients in Jeopardy
prnewswire.com
GILD
Cell Counting Market is expected to generate a revenue of USD 16.5 Billion by 2031, Globally, at 6.20% CAGR: Verified Market Research®
globenewswire.com
TMO
BIO
BDX
AMZN
AGNC
DHR
GEHC
OC
ABT
TEC
GILD
BMY
MRK
Immuno-Oncology Drugs Market Projected to Reach US$ 185.69 Billion by 2035 | Astute Analytica
globenewswire.com
VRTX
MRK
BMY
GILD
JNJ
AZN
NVS
REGN
AMGN
PFE
BIIB
ISRG
MDLZ
IMCR
CRSP
EDIT
NCLH
ACRS
ALNY
INCY
ABBV
LULU
EXAS
RDVY
ONCY
GENM
DTIL
XAIR
CGEN
ADPT
ATRC
CODX
CORT
CRBU
CTAS
CYTK
DASH
DECK
DOCU
EBAY
ELAN
ENPH
EPAM
FIVN
FORM
FTNT
GDRX
GEHC
GNTX
GOOS
GRMN
GTLB
HGV
HLT
HOLX
HON
HPE
HPQ
HRB
HSIC
HWM
IDXX
ILMN
INSM
INTC
INTU
IRTC
ITRI
IVZ
JBL
JEF
JHG
JLL
JPM
KDP
KHC
KODK
LAKE
LCID
LRCX
LSCC
LYFT
MCHP
MELI
MGM
MKTX
MLCO
MNST
MRVL
MTCH
MU
NDSN
NEO
NET
NFLX
NKE
NOC
NOW
NRG
NTAP
NTES
NVDA
NXPI
ODFL
OMC
ON
ORCL
ORLY
OSK
OTIS
OXY
PANW
PAYX
PCAR
PCG
PDD
PEP
PGR
PH
PHG
PII
PKX
PLAB
PLD
PLUG
PM
PNW
POOL
POST
PPG
PPL
PRGS
PRGO
PRLB
PRO
PRTA
PSFE
PSNY
PTC
PVH
QCOM
QGEN
QRVO
RBLX
RCL
RDNT
REI
REIT
RF
RGEN
RIVN
RL
RMBS
RMD
ROBT
ROKU
ROST
RPRX
RS
RSG
RSP
RVSN
RYAAY
S
SABR
SAN
SAVA
SBAC
SBRA
SBUX
SCHD
SCL
SD
SE
SEDG
SEE
SEIC
SELF
SEM
SIRI
SJM
SKX
SLB
SLGN
SMCI
SMLR
SNBR
SNOW
SNPS
SO
SONO
SPCE
SPGI
SPNS
SQM
SRPT
SSNC
ST
STAG
STLD
STNG
STOK
STX
SUN
SWKS
SYK
SYY
T
TAL
TAN
TCOM
TDOC
TECK
TEF
TEK
TEL
TER
TFX
TGT
TGTX
THC
THO
TIGR
TITN
TJX
TLRY
TMO
TMUS
TNDM
TNET
TOL
TOPS
TORO
TPH
TPL
TQQQ
TR
TRC
TRIP
TRMB
TRMK
TRN
TRP
TRT
TRVG
TS
TSCO
TSE
TSLA
TSN
TT
TTC
TTD
TTI
TTNP
TTWO
TU
TUSK
TV
TVC
TVE
TW
TWLO
TX
TXN
TXRH
TXT
TYL
U
UAL
UBER
UDR
UEC
UHAL
ULTA
UMC
UMH
UNFI
UNH
UNIT
UNM
UPST
URBN
USA
USFD
USNA
USPH
UTHR
V
VRSK
VTR
VTRS
VZ
W
WAB
WDC
WEC
WELL
WEN
WERN
WEX
WFC
WGO
WHD
WHR
WIA
WMB
WMT
WNS
WPC
WRB
WST
WTAI
WTFC
WTS
WU
WY
WYNN
XBIT
XCUR
XENE
XFLT
XGN
XHR
XLP
XOM
XPO
XRAY
XRT
XTLB
XXII
XYL
YETI
YMM
YPF
YUM
Z
ZBRA
ZCMD
ZIM
ZION
ZKIN
ZNTL
ZTO
ZTS
ZYME
SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook, 2030 - Ongoing Global Trials and Promising Candidates Like Sovleplenib Create Strong Investment and Innovation Opportunities
globenewswire.com
RIGL
GILD